Concepedia

Gail Murphy

GM

17

Publications

1K

Citations

16

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Sahlgrenska University Hospital

Worldwide Clinical Trials (United States)

Scynexis (United States)

Gail Murphy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1988–2018

17

Publications

17

Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure<sup>1</sup>

Johan Svensson, Lars Lönn, John‐Olov Jansson et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 161 citations · Full text

Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men

Hong Sun, William P. Kennedy, Darren Wilbraham et al. · SLEEP · 2013 · 158 citations · Full text

Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men

Jeffrey S. Barrett, Gail Murphy, Kathelijne Peerlinck et al. · Clinical Pharmacology & Therapeutics · 1994 · 131 citations

Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans

Arthur Bergman, Gail Murphy, Joanne Burke et al. · The Journal of Clinical Pharmacology · 2004 · 99 citations

, , +10

Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults<sup>1</sup>

Ian Chapman, Ora Hirsch Pescovitz, Gail Murphy et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 63 citations · Full text

Rows per page

1–5 of 17